Let's Play PET References - "S"

[Back to Menu] [Back to Index]
  • Sackeim, H, Prohovnik, I, Moeller, J, Mayeux, R, Stern, Y, Devanand, D. Regional cerebral blood flow in mood disorders. 2. Comparison of major depression and Alzheimer's disease. J Nucl Med, 34:1090-1101, 1993.

  • Sadzot B, Sheldon J, Dannals R, Ravert H, Wagner H Jr; Frost J. Localization of peripheral cholecystokinin receptors in vivo using the cholecystokinin antagonist [3H](+/-)-MK-329. Eur J Pharmacol, 185:195-201, 1990.

  • Saha G, Go R, MacIntyre W. Radiopharmaceucticals for cardiovascular imaging. Int J Radiat Appl Instr B Nucl Med Biol, 19:1-20, 1992.

  • Saha GB, MacIntyre WJ,Go RT. Cyclotrons and positron emission tomography radiopharmaceuticals for clinical imaging. Seminars in Nuclear Medicine, 1992, 22:150-61.

  • Saji H, Tsutsumi D, Kiso Y, Iimuma S, Mimoto T, Akaji K, et al. Synthesis and biological evaluation of a 13N-labeled opioid peptide. Int J Radiat Appl Instr B Nucl Med Biol, 19:455-60, 1992.

  • Saji H, Tsutsumi D, Magata Y, Iida Y, Konishi J, Yokoyama A. Preparation and biodistribution in mice of [11C]carfentanil: a radiopharmaceutical for studying brain mu-opioid receptors by positron emission tomography. Ann Nucl Med, 6:63-7, 1992.

  • Sasaki, M, Ichiya, Y, Kuwabara, Y, Otsuka, M, Fukumura, T, Kawai, Y, Koga, H, Masuda, K. Fluorine-18-Fluorodeoxyglucose positron emission tomography in Technetium-99m - Hydroxymethylenediphosphate negative bone tumors. J Nucl Med, 34: 288-290, 1993.

  • Satyamurthy, N, Barrio, J, Bida, G, Huang, S, Mazziotta, J, Phelps, M: 3-(2'- [18F] fluoroethyl)spiperone, a potent dopamine antagonist: synthesis, structural analysis and in-vivo utilization in humans. Int J Rad Appl Instr, 41:113-29, 1990.

  • Savic, I, Ingvar, M, Stoneelander, S. Comparison of [C-11]Flumazenil and [F-18]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiat, 56: 615-21, 1993.

  • Sawada Y, Kawai R, McManaway M, Otsuki H, Rice K, Patlak C, Blasberg R. Kinetic analysis of transport and opioid receptor binding of [3H](-)-cyclofoxy in rat brain in vivo: implications for human studies. J Cereb Blood Flow Metab, 11:183-203, 1991.

  • Sawle, G, Bloomfield, P, Bjšrklund, A, et al: Transplantation of fetal dopamine neurons in Parkinson's disease: positron emission tomography [18F]-6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol, 31:166-73, 1992.

  • Sawle, G, Myers, R. The role of positron emission tomography in the assessment of human neurotransplantation. Trends Neurosci, 16:186-92, 1993.

  • Sawle, G, Wroe, S, Lees, A, Brooks, D, Frackowiak, R: The identification of presymptomatic Parkinsonism: Clinical and [18F]Dopa positron emission tomography studies in an Irish kindred. Ann Neurol, 32:609-17, 1992.

  • Scheibel, ME, Scheibel, AB. Structural changes in the aging brain. In: Aging, Volume 1, Brody, H, Harman, D, Ordy, JM, Eds., Raven, New York, 1975, pp. 11-37.

  • Schelbert, H: Positron emission tomography for the assessment of myocardial viability. Circulation , 84:1122-1131, 1991.

  • Schelbert, H, Henze, E, Schon, H, Keen, R, Hansen, W, Selin, C, et al.: C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography: III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Am Heart J , 105:492-504, 1983.

  • Schelbert, H, Phelps, M, Hoffman, E, Huang, S and Kuhl, D: Regional myocardial blood flow, metabolism and function assessed noninvasively by positron emission tomography. Am J Card , 46:1269-1277, 1980.

  • Schelbert, H, Wisenberg, G, Phelps, M, Gould, K, Marshall, R, Hoffman, E, et al.: N-13 ammonia and positron emission computed axial tomography for the noninvasive assessment of coronary artery disease in man. Adv Clin Cardiol, 1:394-405, 1980.

  • Schelbert, H and Czernin, J: Editorial: Noninvasive quantification of regional myocardial blood flow: Assessment of myocardial perfusion reserve and collateral circulation. J Nucl Med , 31:271-273, 1990.

  • Schelbert, H and Schwaiger, M: PET studies of the heart. Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart , 12:581-661, 1986.

  • Schelbert, H, Henze, E, Keen, R, Schon, H, Hansen, H, Selin, C, et al.: C-11 Palmitate for the Noninvasive Evaluation of Regional Myocardial Fatty Acid Metabolism with Positron Computed Tomography. IV In Vivo Evaluation of Acute, Experimentally Induced Myocardial Ischemia. Amer Heart J, 106:736-750, 1983.

  • Schelbert, H, Henze, E, Sochor, H, Grossman, R, Huang, SC, Barrio, J, et al.: Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction. Am Heart J , 111:1055-64, 1986.

  • Schelbert, H, Wisenberg, G, Phelps, M, Gould, K, Henze, E, Hoffman, E, et al.: Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in man with intravenous N-13 ammonia and positron computed tomography. Am J Cardiol , 49:1197-1207, 1982.

  • Schelbert, H: Editorial: Euglycemic Hyperinsulinemic Clamp and Oral Glucose Load in Stimulating Myocardial Glucose Utilization During Positron Emission Tomography. J Nucl Med , 33:1263-1266, 1992.

  • Schifter, T, Hoffman, J, Hanson, M, Boyko, O, Beam, C, Paine, S, Schold, S, Burger, P, Coleman, R. Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomog, 17:509-16, 1993.

  • Schwaiger, M, Brunken, R, Grover-McKay, M, Krivokapich, J, Child, J, Tillisch, J, et al.: Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol , 8:800-8, 1986.

  • Schwaiger, M, Brunken, R, Krivokapich, J, Child, J, Tillisch, J, Phelps, M, et al.: Beneficial effect of residual anterograde flow on tissue viability as assessed by positron emission tomography in patients with myocardial infarction. Eur Heart J , 8:981-8, 1987.

  • Selkoe, DJ. Amyloid protein and Alzheimer's disease. Sci. Amer., 265:40-47, 1991.

  • Selkoe, DJ. The molecular pathology of Alzheimer's disease. Neuron, 6:487-498, 1991.

  • Shelton M; Dence C; Hwang D; Herrero P; Welch M; Bergmann S. In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardized myocardium. J Amer Coll Cardiol, 1990, 16:477-85.

  • Shelton M; Dence C; Hwang D; Welch M; Bergmann S. Myocardial kinetics of fluorine-18 misonidazole: a marker of hypoxic myocardium. J Nucl Med, 1989, 30:351-8.

  • Shinotoh, H, Hirayama, K, Tateno, Y: Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET. Adv Neurol, 60:488-93, 1993.

  • Small, GW, Kuhl, DE, Riege, WH, Fujikawa, DG, Ashford, JW, Metter, EJ, Mazziotta, JC: Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset. Arch. Gen. Psychiat., 46:527-532, 1989.

  • Sochor, H, Schelbert, H, Schwaiger, M, Henze, E and Phelps, M: Studies of fatty acid metabolism with positron emission tomography in patients with cardiomyopathy. Eur J Nucl Med , S66-9, 1986.

  • Sokoloff, L, Reivich, M, Kennedy, C, et al: The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem., 28:897-916, 1977.

  • Sorenson,JA, Phelps, ME. Physics in Nuclear Medicine. Grune & Stratton, New York, 1980.

  • Stefan, H, Pawlik, G, Bocher-Schwarz, H, Biersack, H, Burr, W, Penin, H, Heiss, W. Functional and morphological abnormalities in temporal lobe epilepsy: A comparison of interictal and ictal EEG, CT, MRI, SPECT, and PET. J Neurol, 234:377-84, 1987.

  • Strauss, LG, Clorius, JH, Schlag, P, et al: Recurrence of colorectal tumors: PET evaluation. Radiology, 170:329-332, 1989.

  • Strauss, LG, Conti, PS. The application of PET in clinical oncology. J Nucl Med, 32:623-648, 1991.

  • Suehiro M, Scheffel U, Dannals R, Ravert H, Ricaurte G, Wagner H Jr. A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z. J Nucl Med, 34:120-7, 1993.

  • Suhara, T, Inoue, O, Kobayashi, K, Suzuki, K, Tateno, Y. Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography. Neurosci Lett, 149: 225-8, 1993.

  • Suhara T; Nakayama K; Inoue O; Fukuda H; Shimizu M; Mori A; Tateno Y. D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology, 106:14-8, 1992.

  • Swaab, DF, Fliers, E. Clinical strategies in the treatment of Alzheimer's disease. Prog. Brain Res., 70:413-427, 1986.

  • Swart J; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning. J Cereb Blood Flow Metab, 10:297-306, 1990.

  • Syrota A; Jehenson P. Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission. European J Nucl Med, 1991, 18:897-923.

    Let's Play PET, Copyright 1992, 1993 Regents of the University of California
    All Rights Reserved

    [Back to Menu] [Back to Index]